These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 20046141

  • 1. Monitoring for treatment failure in patients on first-line antiretroviral treatment in resource-constrained settings.
    Lynen L, Van Griensven J, Elliott J.
    Curr Opin HIV AIDS; 2010 Jan; 5(1):1-5. PubMed ID: 20046141
    [Abstract] [Full Text] [Related]

  • 2. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K.
    Verh K Acad Geneeskd Belg; 2001 Jan; 63(5):447-73. PubMed ID: 11813503
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The measurement of HIV-1 viral load in resource-limited settings: how and where?
    Rouet F, Rouzioux C.
    Clin Lab; 2007 Jan; 53(3-4):135-48. PubMed ID: 17447649
    [Abstract] [Full Text] [Related]

  • 5. HIV viral load monitoring in resource-limited regions: optional or necessary?
    Calmy A, Ford N, Hirschel B, Reynolds SJ, Lynen L, Goemaere E, Garcia de la Vega F, Perrin L, Rodriguez W.
    Clin Infect Dis; 2007 Jan 01; 44(1):128-34. PubMed ID: 17143828
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Resistance considerations in sequencing of antiretroviral therapy in low-middle income countries with currently available options.
    De Luca A, Prosperi M, Bracciale L.
    Curr Opin HIV AIDS; 2010 Jan 01; 5(1):27-37. PubMed ID: 20046145
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sequencing of antiretroviral therapy in children in low- and middle-income countries.
    Sohn AH, Nuttall JJ, Zhang F.
    Curr Opin HIV AIDS; 2010 Jan 01; 5(1):54-60. PubMed ID: 20046148
    [Abstract] [Full Text] [Related]

  • 12. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S, Antunes OA, Fortunak JM.
    Antiviral Res; 2008 Sep 01; 79(3):143-65. PubMed ID: 18571246
    [Abstract] [Full Text] [Related]

  • 13. Management of antiretroviral failure and resistance in developing countries.
    Hawkins C, Murphy RL.
    Curr Opin HIV AIDS; 2009 Nov 01; 4(6):538-44. PubMed ID: 20048723
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Determinants of virological failure after successful viral load suppression in first-line highly active antiretroviral therapy.
    Geretti AM, Smith C, Haberl A, Garcia-Diaz A, Nebbia G, Johnson M, Phillips A, Staszewski S.
    Antivir Ther; 2008 Nov 01; 13(7):927-36. PubMed ID: 19043927
    [Abstract] [Full Text] [Related]

  • 19. HIV resistance and the developing world.
    Gupta RK, Pillay D.
    Int J Antimicrob Agents; 2007 May 01; 29(5):510-7. PubMed ID: 17346940
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.